- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05590052
Bipolar Electrosurgery Versus Thermocautery in Circumcision With Safe Anesthetic Techniques
Background: Circumcision is the most commonly performed surgical procedure done among the pediatric age group worldwide and is considered to be one of the oldest operations done. Circumcision should be performed properly with safe surgical techniques, with the least possibility of complications.
Objective: To compare bipolar electrosurgery versus thermocautery in the circumcision of infants under combined general and local anesthesia.
Patients and Methods: This prospective randomized comparative study was carried out on 110 infants who were candidates for elective circumcision under combined general and local anesthesia. Infants were randomly allocated into two equal groups (55 infants each); in group A, circumcised by bone-cutting forceps with cutting foreskin using a scalpel and achievement of hemostasis using bipolar electrosurgery, and in group B, circumcised by bone-cutting forceps with cutting foreskin and achievement of hemostasis using thermocautery.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
El-Beheira
-
Damanhūr, El-Beheira, Egypt
- Damanhour Teaching Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Infants of families who applied for circumcision
- Age from 1 to 12 months, of the male sex
- Infants should have normal preoperative laboratory investigations
Exclusion Criteria:
- Infants with congenital malformations especially hypospadias and epispadias, congenital inguinal hernia, and undescended testis
- Infants with acute penile infection, or excess suprapubic fat
- Infants with cardiovascular, neurological, respiratory, liver, renal, endocrine, blood, or immune diseases
- Allergy to any drug will be used in this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Bipolar Electrosurgery group (n=60)
Group A
|
Achievement of hemostasis using bipolar electrosurgery
|
Active Comparator: Thermocautery group (n=60)
Group B
|
achievement of hemostasis using thermocautery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean and Standard deviation of postoperative analgesic doses (mean±SD)
Time Frame: 72 hours after the end of the operation
|
Number of analgesic doses given after the end of the operation
|
72 hours after the end of the operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean and Standard deviation of Operative duration (minutes) (mean±SD)
Time Frame: 2 minutes after the end of the operation
|
Time from holding the penis till dresssing of the penis
|
2 minutes after the end of the operation
|
Number of participants and Rate of Intraoperative complications
Time Frame: 2 minutes after the end of the operation
|
Number of participants and Rate of: Tachycardia, Bradycardia, Laryngeal spasm, Hypoxia, Bleeding, Glans injury, and Vomiting.
|
2 minutes after the end of the operation
|
Number of participants and Rate of Postoperative complications
Time Frame: 4 weeks after the end of the operation
|
Number of participants and Rate of: Bleeding requiring surgical intervention, Penile edema, Wound infection, Meatal stenosis, and Trapped penis.
|
4 weeks after the end of the operation
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- DTH: 22003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Circumcision
-
ProgressusUnknownCircumcision, Male | Circumcision Status: Circumcised, Uncircumcised
-
University of North Carolina, Chapel HillBill and Melinda Gates Foundation; FHI 360; Impact Research & Development OrganizationCompletedVoluntary Medical Male Circumcision | Circumcision AdultKenya
-
Assiut UniversityUnknown
-
University of MichiganCompletedCircumcisionUnited States
-
Weill Medical College of Cornell UniversityBill and Melinda Gates FoundationCompleted
-
King Saud UniversityUnknownCircumcision, MaleSaudi Arabia
-
Simunye Primary Health CareCompleted
-
Medical University of South CarolinaCompleted
Clinical Trials on Bipolar Electrosurgery
-
Northwestern UniversityRecruitingTreatment Side Effects | Treatment | Surgical Complication | Uterine Septum | Septum; UterusUnited States
-
Catholic University of the Sacred HeartUnknown
-
Catholic University of the Sacred HeartUnknown
-
Joint Implant Surgeons, Inc.Medtronic; Mount Carmel Health SystemCompletedArthritis, Rheumatoid | Osteonecrosis | Hip Dislocation, Congenital | Osteoarthritis, Hip | Joint Deformities, AcquiredUnited States
-
Medtronic Surgical TechnologiesCompleted
-
Medtronic Surgical TechnologiesTerminatedBreast CancerUnited States
-
Medtronic Surgical TechnologiesTerminated
-
Cairo UniversityRecruiting
-
Medtronic Surgical TechnologiesTerminatedOsteoarthritis | Degenerative Joint DiseaseUnited States
-
Group of Research in Minimally Invasive TechniquesUniversidad de Zaragoza; Hospital Clínico Universitario Lozano BlesaWithdrawnBenign Prostatic HyperplasiaSpain